Helen M. Thackray, Chief Officer of Biocryst Pharmaceuticals BCRX, has filed 1 purchase and 1 sale on the open market. The latest trade was on 25/03/31.

HT

HT

Helen M. Thackray

Chief R&D Officer

Company

Biocryst Pharmaceuticals BCRX

First filing

23/04/04

Trades

24 trades

Buys / sales

1 / 1

12-month net buying

No record

Last trade

25/03/31

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Biocryst PharmaceuticalsBCRX	Open-market buy	24/05/14	24/05/15	30,000 sh	$5.86	$175,800	+12.4%
Biocryst PharmaceuticalsBCRX	Open-market sale10b5-1 plan	23/04/03	23/04/05	7,000 sh	$8.29	$58,030	−3.3%